Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ROP
DRUG
2 trials
Sponsors
GlaxoSmithKline
, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions
Blindness
ELBW - Extremely Low Birth Weight Infant
Jaundice, Neonatal
Parkinson Disease
Parkinson's Disease
Premature
ROP
Very Low Birth Weight Infant
Phase 4
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
Completed
NCT00485069
GlaxoSmithKline
Parkinson Disease, Parkinson's Disease
Start: 2007-06-30
End: 2009-12-31
Updated: 2010-12-15
Unknown Phase
Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
NCT05806684
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Blindness, ELBW - Extremely Low Birth Weight Infant, Jaundice, Neonatal +3
Start: 2023-05-01
End: 2024-12-31
Target: 1586
Updated: 2023-04-24
Related Papers
Hyperbilirubinemia and retinopathy of prematurity: a retrospective cohort study.
2024-06-15